Response to: Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications, by Jerome Boursier et al.

Poynard, Thierry; Deckmyn, Olivier; Valla, Dominique

Response to: Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications, by Jerome Boursier et al.

Poynard, Thierry; Deckmyn, Olivier; Valla, Dominique.

Affiliation

Poynard T; Groupe Hospitalier Pitie-Salpetriere, Service d'Hepato Gastroenterologie, Paris, France.
Deckmyn O; Groupe Hospitalier Pitie-Salpetriere, Service d'Hepato Gastroenterologie, Paris, France.
Valla D; Groupe Hospitalier Pitie-Salpetriere, Service d'Hepato Gastroenterologie, Paris, France.

Clin Gastroenterol Hepatol ; 21(2): 559-560, 2023 02.

Article in En | MEDLINE | ID: mdl-35398570

Subject(s)

Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Humans; Diabetes Mellitus, Type 2/complications; Liver Cirrhosis/complications; Liver Cirrhosis/diagnosis; Liver Cirrhosis/pathology; Liver/pathology; Biomarkers; Biopsy; Non-alcoholic Fatty Liver Disease/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: France Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google